Abstract
Summary
We did a cross-sectional analysis of chronic pulmonary obstructive disease (COPD) patients without chronic use of systemic glucocorticoids (CUG). Osteoporosis was found in 51% and bone mineral density (BMD) was correlated with severity of disease. Low levels of vitamin D were found in 94%. All COPD patients may benefit from vitamin D supplementation and screening for low BMD.
Introduction
Patients with chronic pulmonary obstructive disease have low bone mineral density, caused by chronic use of systemic glucocorticoids and hypovitaminosis D. However, patients without CUG may also have low BMD.
Methods
We performed a cross-sectional analysis in 49 patients (21 men, 28 postmenopausal women), with COPD without CUG, from Brazil (25° 25' S). Several markers of bone metabolism were measured, plus BMD. Osteoporosis risk factors and history of fractures were investigated. Respiratory function was assessed by venous gasometry, spirometry, and oximetry. BMD results were compared to those of 40 healthy non-smokers controls.
Results
COPD patients had lower BMD at all sites (p < 0.01). Osteoporosis was observed in 51%. BMD independently correlated with stage of disease (lumbar spine, R = 0.38, p = 0.01; total femur, R = 0.36, p = 0.01; femoral neck, R = 0.40, p < 0.01). Ninety-four percent had low levels of vitamin D (<30 ng/mL) and 67% had secondary hyperparathyroidism. Vitamin D was correlated with oxygen saturation (R = 0.36, p = 0.01), with lower levels in those with saturation <88% (p = 0.01).
Conclusion
Patients with COPD without CUG have increased risk for osteoporosis. Such patients have hypovitaminosis D, which is correlated with the severity of disease. Screening for low BMD and vitamin D supplementation may be warranted to all COPD patients.
Similar content being viewed by others
References
Biskobing DM (2002) COPD and osteoporosis. Chest 121(2):609–620
Iqbal F, Michaelson J, Thaler L et al (1999) Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 116(6):1616–1624
Jorgensen NR, Schwarz P (2008) Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 14(2):122–127
Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19(6):893–899
McEvoy CE, Ensrud KE, Bender E et al (1998) Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(3 Pt 1):704–709
Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB (2007) Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int 18(9):1197–1202
Incalzi RA, Caradonna P, Ranieri P et al (2000) Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 94(11):1079–1084
Papaioannou A, Parkinson W, Ferko N et al (2003) Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 14(11):913–917
Karadag F, Cildag O, Yurekli Y, Gurgey O (2003) Should COPD patients be routinely evaluated for bone mineral density? J Bone Miner Metab 21(4):242–246
Fabbri LM, Hurd SS (2003) Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 22(1):1–2
Dubois EF, Roder E, Dekhuijzen PN et al (2002) Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. Chest 121(5):1456–1463
NCAAA. Task Force on Recommended Alcohol Questions—National Council on Alcohol Abuse and Alcoholism Recommended Sets of Alcohol Consumption Questions 2003 [cited 2008 September 15]; Available from:
Lolio C, Souza J, Santo A, Buchalla C (1993) Prevalence of smoking in a city of southeastern Brazil. Rev Saúde Pública 27:4
Lloyd T, Rollings N, Eggli DF et al (1997) Dietary caffeine intake and bone status of postmenopausal women. Am J Clin Nutr 65(6):1826–1830
Expert Panel Report 3 (EPR-3) (2007) Guidelines for the diagnosis and management of asthma—summary report 2007. J Allergy Clin Immunol 120(5 Suppl):S94–S138
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281
Hans D, Downs RW Jr, Duboeuf F et al (2006) Skeletal sites for osteoporosis diagnosis: the 2005 ISCD Official Positions. J Clin Densitom 9(1):15–21
Knudson RJ, Slatin RC, Lebowitz MD, Burrows B (1976) The maximal expiratory flow-volume curves normal standards variability and effect of age. Am Rev Respir Dis 113:587–600
Standardization of Spirometry (1995) 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152(3):1107–1136
Jorgensen NR, Schwarz P, Holme I et al (2007) The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 101(1):177–185
Katsura H, Kida K (2002) A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 122(6):1949–1955
Forli L, Halse J, Haug E et al (2004) Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med 256(1):56–62
Kjensli A, Mowinckel P, Ryg MS, Falch JA (2007) Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 40(2):493–497
Lekamwasam S, Trivedi DP, Khaw KT (2002) An association between respiratory function and bone mineral density in women from the general community: a cross sectional study. Osteoporos Int 13(9):710–715
Lekamwasam S, Trivedi DP, Khaw KT (2005) An association between respiratory function and hip bone mineral density in older men: a cross-sectional study. Osteoporos Int 16(2):204–207
Sin DD, Man JP, Man SF (2003) The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 114(1):10–14
Riancho JA, Gonzalez Macias J, Del Arco C et al (1987) Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax 42(12):962–966
Goldstein MF, Fallon JJ Jr, Harning R (1999) Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 116(6):1733–1749
de Vries F, van Staa TP, Bracke MS et al (2005) Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 25(5):879–884
Elmstahl S, Ekstrom H, Johnell O et al (2006) No association between inhaled corticosteroids and whole body DXA in postmenopausal women. Pharmacoepidemiol Drug Saf 15(7):527–535
Halpern MT, Schmier JK, Van Kerkhove MD et al (2004) Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Ann Allergy Asthma Immunol 92(2):201–207 quiz 7-8, 67
Jones AM, Munavvar M, Vail A et al (2002) Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma. Respir Med 96(11):950–954
Richy F, Bousquet J, Ehrlich GE et al (2003) Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int 14(3):179–190
Bandeira F, Griz L, Dreyer P et al (2006) Vitamin D deficiency: a global perspective. Arq Bras Endocrinol Metabol 50(4):640–646
Saraiva GL, Cendoroglo MS, Ramos LR et al (2005) Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of Sao Paulo (23 degrees 34'S), Brazil. Osteoporos Int 16(12):1649–1654
Dimai HP, Domej W, Leb G, Lau KH (2001) Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res 16(11):2132–2141
Donovan DS Jr, Papadopoulos A, Staron RB et al (1998) Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 157(6 Pt 1):1892–1899
Sutherland ER, Cherniack RM (2004) Management of chronic obstructive pulmonary disease. N Engl J Med 350(26):2689–2697
Black PN, Scragg R (2005) Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 128(6):3792–3798
Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168(15):1629–1637
Thomas MK, Lloyd-Jones DM, Thadhani RI et al (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338(12):777–783
Gerdhem P, Obrant KJ (2002) Effects of cigarette-smoking on bone mass as assessed by dual-energy X-ray absorptiometry and ultrasound. Osteoporos Int 13(12):932–936
Law MR, Hackshaw AK (1997) A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 315(7112):841–846
Szulc P, Garnero P, Claustrat B et al (2002) Increased bone resorption in moderate smokers with low body weight: the Minos study. J Clin Endocrinol Metab 87(2):666–674
Ward KD, Klesges RC (2001) A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 68(5):259–270
Acknowledgments
We thank Dr. Lêda Maria Rabelo for her assistance during the preparation of this manuscript.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Franco, C.B., Paz-Filho, G., Gomes, P.E. et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 20, 1881–1887 (2009). https://doi.org/10.1007/s00198-009-0890-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-009-0890-5